These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1023885)

  • 1. Effect of some antiblastic drugs on HeLa cells.
    D'Ancona S; Adami P; Pederzoli G
    Boll Ist Sieroter Milan; 1976; 55(2):174-84. PubMed ID: 1023885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of peptichemio and of peptichemio plus hydrocortisone on growth and alkaline phosphatase activity in HeLa cells in vitro.
    D'Ancona S; Barberio MT; Adami P; Poltronieri R
    Boll Ist Sieroter Milan; 1980 Mar; 59(1):60-9. PubMed ID: 7459015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
    Mangione F; Taverna L
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study of the effects of some antineoplastic preparations on human tumor cells (HeLa line) in tissue culture by the time lapse microphotography method].
    Shirokova TG; Larionov LF; Komm SG
    Tsitologiia; 1967 Apr; 9(4):483-6. PubMed ID: 4864556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematopoietic stem cells and antiblastic drugs. II. Variations in the colony forming cells in vivo after administration of peptichemio].
    Saviane A; Massa G; Bogliolo G; Pannacciulli I
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):335-9. PubMed ID: 1087887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of various pharmacologic agents on the nucleus and chromosomes of human lymphocytes].
    Bastide P; de Rocca Serra MF; Fellmann N; Jaffray JY; Geneix A; Malet P; Turchini JP
    Cytologia (Tokyo); 1981 Jun; 46(1-2):387-91. PubMed ID: 7273862
    [No Abstract]   [Full Text] [Related]  

  • 8. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacology of anticancer agents [Part 5] Antimetabolites (2)].
    Nakamura T; Ueda T; Uchida M
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):409-20. PubMed ID: 1543370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio].
    Balitskiĭ KP; Veksler IG; Tsapenko VF
    Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C.
    Suhadolnik RJ; Sawada Y; Flick MB; Reichenbach NL; Mosca JD
    Cancer Res; 1983 Nov; 43(11):5462-6. PubMed ID: 6193871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential scanning calorimetry of nuclei as a test for the effects of anticancer drugs on human chromatin.
    Almagor M; Cole RD
    Cancer Res; 1989 Oct; 49(20):5561-6. PubMed ID: 2477145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of the cytostatic agents Bleomycin and Peptichemio.
    Stacher A; Baumgartner G; Höcker P
    Int J Clin Pharmacol; 1973 Apr; 7(2):238-45. PubMed ID: 4125956
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
    Wesierska-Gadek J; Gueorguieva M; Schloffer D; Uhl M; Wojciechowski J
    J Cell Biochem; 2003 Aug; 89(6):1222-34. PubMed ID: 12898520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal effect of bleomycin and peplomycin on HeLa cells in multicell tumor spheroids.
    Sasaki T; Yamamoto M; Kuwahara K
    Cancer Res; 1984 Apr; 44(4):1374-9. PubMed ID: 6200210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dependence of the cytokinetic effects of alkylating antitumor preparations on the phase of the hepatocyte cell cycle in regenerating liver].
    Uryvaeva IV; Sokolov AS; Kalistratov SG; Delone GV
    Izv Akad Nauk SSSR Biol; 1991; (6):816-28. PubMed ID: 1809781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles and clinical pharmacology of cytostatic treatment].
    Schmidt CG
    Verh Dtsch Ges Inn Med; 1980; 86():337-67. PubMed ID: 7223027
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
    Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative analysis of the antiblastic and immunodepressive effect of alkylating agents].
    Kovalev IE; Chernov VA; Maĭskaia LM
    Vopr Onkol; 1969; 15(6):62-4. PubMed ID: 5811126
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of bone marrow homotransplantation on the toxicity and antineoplastic property of some alkylating agents].
    Veksler IG; Shevchenko VN
    Vopr Onkol; 1965; 11(7):71-6. PubMed ID: 4956684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.